The Senate Banking and Insurance Committee has scheduled a hearing for Sept. 13 to determine if it has any regulatory authority over a dispute between two Western Pennsylvania health care giants: UPMC and Highmark.
The two have been battling over a service reimbursement contract that is set to expire June 30, 2012. UPMC is also at odds with Highmark’s plan to invest in a UPMC competitor, West Penn Allegheny Health System, according to a Senate Republican Caucus staffer.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
